• LAST PRICE
    3.7300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    3.2500/ 1
  • Ask / Lots
    4.1700/ 3
  • Open / Previous Close
    0.0000 / 3.7300
  • Day Range
    ---
  • 52 Week Range
    Low 2.5600
    High 5.8500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 3.68
TimeVolumeCAPR
09:32 ET22283.61
09:34 ET1003.62
09:41 ET8003.66
09:45 ET2003.67
09:52 ET6003.68
09:56 ET63253.65
10:01 ET1003.67
10:06 ET4903.6415
10:15 ET14053.69
10:19 ET1003.69
10:24 ET4383.72
10:32 ET20003.7338
10:33 ET12003.7246
10:35 ET23333.78
10:37 ET2003.74
10:39 ET1003.77
10:44 ET6003.77
10:46 ET3133.74
10:55 ET10003.7225
10:57 ET1003.75
11:00 ET1003.73
11:02 ET5113.75
11:18 ET1003.77
11:31 ET2003.73
11:47 ET1003.71
11:54 ET1003.75
11:58 ET1003.75
12:00 ET1003.75
12:20 ET8003.765
12:27 ET8003.8
12:39 ET54553.77
12:43 ET2003.75
12:50 ET8003.7305
12:57 ET1003.73
01:08 ET3003.755
01:12 ET3003.73
01:14 ET34003.74
01:15 ET28603.785
01:17 ET13003.81
01:19 ET20003.77
01:21 ET36663.77
01:24 ET35003.75
01:26 ET73283.77
01:28 ET13203.74
01:30 ET50003.745
01:37 ET6003.7564
01:44 ET102983.69
01:53 ET1003.75
02:00 ET4003.71
02:08 ET1003.745
02:13 ET5003.77
02:15 ET1003.73
02:18 ET1803.73
02:29 ET1003.73
02:44 ET1003.73
02:47 ET5003.77
03:21 ET1003.69
03:27 ET1203.715
03:30 ET2003.69
03:32 ET3003.69
03:43 ET6793.71
03:48 ET51993.715
03:50 ET1003.715
03:52 ET9533.73
03:54 ET9543.73
03:57 ET3003.7
03:59 ET28163.73
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCAPR
Capricor Therapeutics Inc
90.7M
-3.9x
---
United StatesCADL
Candel Therapeutics Inc
91.0M
-2.5x
---
United StatesXLO
Xilio Therapeutics Inc
91.2M
-1.1x
---
United StatesANIX
Anixa Biosciences Inc
91.4M
-5.8x
---
United StatesELYM
Eliem Therapeutics Inc
91.9M
-1.8x
---
United StatesGALT
Galectin Therapeutics Inc
87.9M
-2.6x
---
As of 2022-07-06

Company Information

Capricor Therapeutics, Inc. is a biotechnology company that is focused on developing transformative cell and exosome-based therapeutics and vaccines for treating and preventing a broad spectrum of diseases. The Company consists of cell therapy program, including CAP-1002 for Duchenne Muscular Dystrophy program and CAP-1002 with CAP-1002 for coronavirus (COVID-19). The Company’s lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy. CAP-1002 is in clinical development for treating Duchenne muscular dystrophy and the cytokine storm associated with COVID-19. Capricor is also developing its exosome technology therapeutic platform. The Company is focused on developing exosomes capable of delivering nucleic acids, including messenger RNA (mRNA) as well as proteins, to treat or prevent a range of diseases. CAP-1002 cell therapy programs initiated Pivotal Phase III, HOPE-3.

Contact Information

Headquarters
2ND FLOOR, 8840 WILSHIRE BLVDBEVERLY HILLS, CA, United States 90211
Phone
310-358-3200
Fax
302-655-5049

Executives

Executive Chairman of the Board
Frank Litvack
President, Chief Executive Officer, Director
Linda Marban
Chief Financial Officer, Principal Accounting Officer
Anthony Bergmann
Executive Vice President, General Counsel
Karen Krasney
Independent Director
Earl Collier

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$90.7M
Revenue (TTM)
$204.1K
Shares Outstanding
24.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
5.12
EPS
$-0.96
Book Value
$1.30
P/E Ratio
-3.9x
Price/Sales (TTM)
444.6
Price/Cash Flow (TTM)
---
Operating Margin
-11,416.42%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.